6-(2-Fluoro-phen-yl)-5,6-dihydro-benzimidazolo[1,2-c]quinazoline.

Acta Crystallogr Sect E Struct Rep Online

College of Chemistry and Materials Science, Fujian Normal University, Fuzhou, Fujian 350007, People's Republic of China.

Published: October 2008

In the title compound, C(20)H(14)FN(3), the pyrimidine ring adopts a half-chair conformation. The dihedral angle between the benzimidazole ring system and the fluoro-phenyl ring is 84.18 (10)°. In the crystal structure, mol-ecules are linked into a two-dimensional network parallel to the bc plane by N-H⋯N and C-H⋯F hydrogen bonds.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959727PMC
http://dx.doi.org/10.1107/S1600536808031875DOI Listing

Publication Analysis

Top Keywords

6-2-fluoro-phen-yl-56-dihydro-benzimidazolo[12-c]quinazoline title
4
title compound
4
compound c20h14fn3
4
c20h14fn3 pyrimidine
4
pyrimidine ring
4
ring adopts
4
adopts half-chair
4
half-chair conformation
4
conformation dihedral
4
dihedral angle
4

Similar Publications

Article Synopsis
  • - The study reviews the effectiveness of combining gemcitabine and erlotinib (Gem-Erlo) for pancreatic cancer treatment, noting mixed results from past randomized controlled trials (RCTs) regarding its benefits over standard chemotherapy.
  • - Comprehensive literature analysis included seven RCTs and 2,152 patients, focusing on various performance metrics such as disease control rate (DCR), overall survival (OS), and progression-free survival (PFS).
  • - Findings indicate that while Gem-Erlo enhances DCR, it does not significantly improve overall survival, progression-free survival, or response rate compared to gemcitabine alone.
View Article and Find Full Text PDF

2-Chloro-4-sulfonylquinazolines undergo functional group swap when treated with an azide nucleophile: 1) the azide replaces the sulfonyl group at the C4 position; 2) the intrinsic azide-tetrazole tautomeric equilibrium directs the nucleofugal sulfinate from the first step to replace chloride at the C2 position. This transformation is effective with quinazolines bearing electron-rich substituents. Therefore, the title transformations are demonstrated on the 6,7-dimethoxyquinazoline core, which is present in pharmaceutically active substances.

View Article and Find Full Text PDF

An unprecedented meglumine-based three-component deep eutectic solvent (3c-DES) (MegPAc) was synthesized using meglumine, p-toluenesulfonic acid (PTSA), and acetic acid as a renewable, and non-toxic solvent. The exploitation of the MegPAc as an eco-friendly reaction media to construct a selective and sensitive small organic molecular sensing probe, namely, pyrazolo[5,1-b]quinazoline-3-carboxylates (PQCs) was executed. Captivatingly, the MegPAc served the dual role of solvent and catalyst, and it delivered the title components with 69-94 % yields within 67-150 minutes.

View Article and Find Full Text PDF

Cancer is considered a silent killer. The complexity of cancer makes it earn that title. So far there are only a few approaches to treat cancer.

View Article and Find Full Text PDF

Two new quinazoline derivatives (2a and 2b) were successfully synthesized in this work using the condensation technique in excellent yields. Using spectroscopic techniques and elemental analyses, the compounds were completely characterized. Density functional theory (DFT) computations have been used to examine the title compound's reactive characteristics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!